Campbell Bradley L's Form 4 filing
Amicus Therapeutics, Inc. (FOLD) · filed Mar 5, 2024
- Accession no.
- 0000950170-24-026266
- Filed
- Mar 5, 2024
- Trade date
- Mar 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $208.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Campbell Bradley LCIK 0001400971 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +7,500 | $8.61 | +$64,575 | 878,719 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +8,333 | $12.28 | +$102,329.24 | 887,052 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −15,833 | $13.14 | −$208,045.62 | 871,219 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 67,500 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −8,333 | $0.00 | $0 | 75,001 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.